Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
173896 ARTíCULOS , VIENDO DEL 172381 AL 172395
Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment?
Rehman S, Nabi B, Zafar A, Baboota S, Ali J.
Expert Opin Drug Deliv. 2019 Oct 30. doi: 10.1080/17425247.2019.1684895. [Epub ahead of print]
0
0
0
McNaney R, Miller N, Vines J, Olivier P, Ladha K, Jackson D, Walker R.
J Rehabil Assist Technol Eng. 2019 Oct 15;6:2055668319852529. doi: 10.1177/2055668319852529. eCollection 2019 Jan-Dec.
0
0
0
Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson's Disease Cohort.
Jeyadevan A, Bakeberg MC, Byrnes M, Kenna J, Ghosh S, Stell R, Walters S, Evans T, McGregor S, Horne M, Mastaglia FL, Anderton RS.
Parkinsons Dis. 2019 Oct 1;2019:2672075. doi: 10.1155/2019/2672075. eCollection 2019.
0
0
0
Goldstein O, Gana-Weisz M, Cohen-Avinoam D, Shiner T, Thaler A, Cedarbaum JM, John S, Lalioti M, Gurevich T, Bar-Shira A, Mirelman A, Giladi N, Orr-Urtreger A.
Mol Genet Metab. 2019 Oct 13. pii: S1096-7192(19)30646-8. doi: 10.1016/j.ymgme.2019.10.001. [Epub ahead of print]
0
0
0
Illés A, Balicza P, Molnár V, Bencsik R, Szilvási I, Molnar MJ.
BMC Neurol. 2019 Oct 28;19(1):260. doi: 10.1186/s12883-019-1496-y.
0
0
0
Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macia
Mov Disord. 2019 Oct 29. doi: 10.1002/mds.27864. [Epub ahead of print]
0
0
0
The Parkinson's Disease Mendelian Randomization Research Portal.
Noyce AJ, Bandres-Ciga S, Kim J, Heilbron K, Kia D, Hemani G, Xue A, Lawlor DA, Smith GD, Duran R, Gan-Or Z, Blauwendraat C, Gibbs JR; 23andMe Research Team5, International Parkinson's Disease Genomic
Mov Disord. 2019 Oct 28. doi: 10.1002/mds.27873. [Epub ahead of print]
0
0
0
DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease
Ozaki Y, Yoshino Y, Yamazaki K, Ochi S, Iga JI, Nagai M, Nomoto M, Ueno SI.
Acta Neurol Scand. 2020 Feb;141(2):177-182. doi: 10.1111/ane.13186. Epub 2019 Nov 16.
0
0
0
A quick test of cognitive speed can predict development of dementia in Parkinson's disease.
Jalakas M, Palmqvist S, Hall S, Svärd D, Lindberg O, Pereira JB, van Westen D, Hansson O.
Sci Rep. 2019 Oct 28;9(1):15417. doi: 10.1038/s41598-019-51505-1.
0
0
0
Soundy A, Collett J, Lawrie S, Coe S, Roberts H, Hu M, Bromley S, Harling P, Reed A, Coeberg J, Carroll C, Dawes H.
Behav Sci (Basel). 2019 Oct 10;9(10). pii: E107. doi: 10.3390/bs9100107.
0
0
0
Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson's Disease Models.
Zhang Y, Guo H, Guo X, Ge D, Shi Y, Lu X, Lu J, Chen J, Ding F, Zhang Q.
Int J Environ Res Public Health. 2019 Oct 10;16(20). pii: E3811. doi: 10.3390/ijerph16203811.
0
0
0
Bergenin Ameliorates MPTP-Induced Parkinson's Disease by Activating PI3K/Akt Signaling Pathway.
Ji Y, Wang D, Zhang B, Lu H.
J Alzheimers Dis. 2019 Oct 21. doi: 10.3233/JAD-190870. [Epub ahead of print]
0
0
0
Levodopa-Induced Hyperventilation Observed in a Parkinson's Disease Patient.
Hattori A, Tsunemi T, Shimada T, Nakagawa E, Hattori N.
Can J Neurol Sci. 2019 Oct 8:1-2. doi: 10.1017/cjn.2019.306. [Epub ahead of print] No abstract available.
0
0
0
Weaver KE, Goldman JG, Ribbens N, Rasmussen HE, Gustashaw KAR, Tangney CC.
J Nutr Gerontol Geriatr. 2020 Jan-Mar;39(1):30-43. doi: 10.1080/21551197.2019.1683116. Epub 2019 Oct 26.
0
0
0
Gaprielian P, Scott SH, Lowrey C, Reid S, Pari G, Levy R.
J Neuroeng Rehabil. 2019 Oct 26;16(1):124. doi: 10.1186/s12984-019-0598-5.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
